Wednesday, June 10, 2026

Drug profile · INN

all-transretinoic

all-transretinoic is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 4
News articles 0
Drug details — all-transretinoic
Class
Route
Patents
0
Programs
4
Data quality
0.70